Matching Antibiotics to susceptible bacteria
|
Antibiotics
|
Bacteria
|
Notes
|
|
Natural Penicillin
(PCN G / PCN V) |
↦ Strep
↦ Staph (non-β-lactamase) ↦ Treponema pallidum (syphilis) |
DOC for Syphilis
|
|
Anti-Staph. Penicillin
(Nafcillin / Dicloxacillin) |
↦ Staph. aureus (penicillinase-producing)
↦ Some Strep |
DOC for MSSA infections
|
|
Aminopenicillins
(Ampicillin / Amoxicillin) |
↦ Streptococcus spp.
↦ Enterococcus faecalis ↦ Enterobacteriaceae (some) ↦ Listeria monocytogenes |
DOC for susceptible Enterococcus and Listeria infections
|
|
Amoxicillin/clavulanate (Augmentin®)
|
↦ Strep + Staph. aureus
↦ E. coli + Klebsiella ↦ H. flu + Moraxella catarrhalis ↦ Anaerobes |
Mixed infections:
(GP+GN+anaerobes) such as Diabetic Foot Ulcers |
|
Ampicillin/sulbactam (Unasyn®)
|
Similar to Amoxicillin/clavulanate + broader activity against anaerobes
(sulbactam = acinetobacter) |
Mixed infections:
(GP+GN+anaerobes) such as Diabetic Foot Ulcers |
|
Piperacillin/tazobactam (Zosyn®)
|
Similar to Amoxicillin/clavulanate + Pseudomonas aeruginosa
|
Same as above PLUS Pseudomonas
|
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
1st Generation
(Cefazolin / Cephalexin) |
↦ Streptococcus + Staph (including some MSSA)
↦ PEK: Proteus, E. coli, Klebsiella pneumoniae |
SSTI
Surgical prophylaxis |
|
2nd Generation
(Cefoxitin / Cefotetan) |
Enhanced activity against gram (–) bacteria including
↦ Some anaerobes (B. fragilis) ↦ Streptococcus + Staph (including some MSSA) ↦ H. flu + Enterobacter aerogenes |
Intra-abdominal infections
Prophylaxis pre-surgery |
|
2nd Generation
(Cefuroxime / Cefaclor) |
↦ Streptococcus + Staph (including some MSSA)
↦ H. influenzae + M. catarrhalis + Neisseria (some) ↦ E. coli + K. pneumoniae |
URT infections
|
|
3rd Generation
(Ceftriaxone / Ceftazidime) |
Broad spectrum including
↦ Many gram (–) bacteria ↦ Streptococcus + Staph (including some MSSA) ↦ H. influenzae + M. catarrhalis + Neisseria ↦ (Ceftazidime = Pseudomonas) |
Meningitis
Gonorrhea (Ceftriaxone) |
|
3rd Generation
(Cefixime / Cefpodoxime / Cefdinir) |
↦ Streptococcus + Staph (including some MSSA)
↦ H. influenzae + M. catarrhalis ↦ Enterobacteriaceae: E. coli + K. pneumoniae |
Community-acquired infections
|
|
4th Generation
(Cefepime) |
Broad-spectrum activity including
↦ Pseudomonas aeruginosa ↦ Many gram (–) bacteria ↦ Streptococcus + Staph (including some MSSA) |
HAP
Febrile neutropenia |
|
5th Generation/Anti-MRSA
(Ceftaroline) |
Broad spectrum including
↦ MRSA + Streptococcus spp ↦ Some gram (–) bacteria |
SSTI
CAP |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Imipenem/Cilastatin
Meropenem |
↦ Gram (+) – Not Enterococcus faecium
↦ Gram (–) & Pseudomonas ↦ Anaerobes |
↦ DOC for Enterobacter, Serratia and ESBL
↦ Severe hospital-acquired infections ↦ Complicated infections |
|
Ertapenem
|
↦ Gram (+) cocci
↦ Many Gram (–) rods ↦ Anaerobes ↦ Less active against Pseudomonas and Acinetobacter |
↦ CAP
↦ Complicated intra-abdominal infections |
|
Meropenem/Vaborbactam
Imipenem/Cilastatin/Relebactam |
Same as ABOVE PLUS
↦ Resistant gram (–) such as CRE |
↦ Complicated UTIs
↦ HAP/VAP |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Aztreonam
|
↦ ONLY Gram (–) including Neisseria, H. flu, Enterobacteriaceae, and Pseudomonas
↦ No anaerobes |
↦ Alternative agent for GRAM (-) infections in those with PCN allergies
↦ Mainly for hospital related infections, critically ill, or sepsis. |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Vancomycin
|
↦ ONLY gram (+) including MRSA and sensitive Enterococci
↦ PO for C. diff |
↦ For either resistant infections or beta-Lactam allergies
↦ Must monitor levels: AUC/MIC ratio ↦ PO can be used for C. diff infections |
|
Televancin
|
↦ Only Gram (+) including MRSA and sensitive Enterococci
↦ DOES NOT cover VRE |
↦ Potentially can be used for Vancomycin-resistant S. aureus (VRSA)
↦ Increase mortality when used for HAP with renal impairment ↦ Contraindicated in pregnancy |
|
Dalbavancin
|
↦ Only Gram (+) including MRSA and sensitive Enterococci
|
↦ Skin/Soft Tissue Infections (SSTIs)
|
|
Oritavancin
|
↦ Only Gram (+) including MRSA and sensitive Enterococci
↦ COVERS VRE |
↦ Skin/Soft Tissue Infections (SSTIs)
|
|
Daptomycin
|
ONLY Gram (+) and for resistance infection including
↦ MRSA/MSSA/VISA/VRSA ↦ Enterococci (include VRE) ↦ Streptococcus |
↦ Alternative agent for GRAM (-) infections in those with PCN allergies
↦ Mainly for hospital related infections, critically ill, or sepsis. |
|
Colistin
|
Resistant Gram (–) infections including Pseudomonas
|
For resistant Gram (-) infections
|
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Erythromycin
|
↦ Gram (+)
↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. |
↦ CAP / Sinusitis / Otitis Media
↦ Atypical infections ↦ Lyme’s disease |
|
Clarithromycin
|
↦ Gram (+)
↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media
↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections |
|
Azithromycin
|
↦ Gram (+), but less activity
↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media
↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections ↦ Frequently used as one time dose (1 g) for Chlamydia treatment. |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Erythromycin
|
↦ Gram (+)
↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. |
↦ CAP / Sinusitis / Otitis Media
↦ Atypical infections ↦ Lyme’s disease |
|
Clarithromycin
|
↦ Gram (+)
↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media
↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections |
|
Azithromycin
|
↦ Gram (+), but less activity
↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media
↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections ↦ Frequently used as one time dose (1 g) for Chlamydia treatment. |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Tetracycline
Doxycycline Minocycline |
Gram (+)
↦ MRSA & Streptococcus Some Gram (-) ↦ Atypical infections ↦ Chlamydia/gonorrhea ↦ Tick borne disease |
↦ Tick or spider bites
↦ Lyme’s Disease ↦ CAP ↦ SSTI, esp. MRSA ↦ Atypical respiratory infections |
|
Tigecycline
|
Gram (+)
↦ MRSA & Streptococcus ↦ VRE Some Gram (-) Some Anaerobe Atypical infections |
↦ Chlamydia/gonorrhea
↦ Tick borne disease ↦ Complicated IAI ↦ Skin/soft tissue infections ↦ MRSA/VRE infections |
|
Eravacycline
Omadacycline |
Gram (+)
↦ MRSA & Streptococcus ↦ VRE Some Gram (-) Some Anaerobe Atypical infections |
↦ SSTI
↦ CAP ↦ Complicated intra-abdominal infection (IAI) |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Tobramycin
Gentamicin Amikacin |
↦ Gram (-) + Pseudomonas
↦ Gram (+) → Synergy dosing for Enterococcal infective Endocarditis ↦ Amikacin only covers mycobacterium sp. |
↦ Resistant G- infections
↦ Synergy with beta-lactam/glycopeptide in enterococcal endocarditis |
|
Plazomicin
|
↦ Gram (-) + Pseudomonas
↦ Gram (+) → Synergy w/ with a beta-lactam/glycopeptide for Enterococcal infective Endocarditis ↦ CRE |
↦ Resistant G- infections, including UTI
↦ Plague |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Linezolid
|
ALL Gram (+) organisms
↦ MsSA/MRSA/VISA/VRSA ↦ Enterococci (VRE) ↦ Streptococcus Some Atypicals |
↦ SSTIs
↦ Suspected MRSA / VRE infections |
|
Tedizolid
|
Same as ABOVE PLUS
↦ Gram (-) anaerobes |
↦ SSTIs
|
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Lincosamide
(Clindamycin) |
↦ Gram (+) → MSSA + some MRSA
↦ Anaerobes (esp. mouth) including Peptostreptococcus, Bacteroides, Prevotella, and Fusobacterium Strep + Staph infections |
↦ DOC for Pelvic Inflammatory Disease (PID)
↦ Used in combo with PCN for toxin producing strains for Clostridium perfringens and S. pyogenes; commonly occurs with necrotizing fasciitis ↦ Alternative for G+ infections with PCN allergy ↦ Dental infections, IAI, and Pelvic infections ↦ Can be used topically for acne |
|
Pleuromutilin
(Lefamulin) |
↦ Gram (+) organisms
↦ Gram (-) organisms (limited) ↦ Atypicals |
↦ CAP
|
|
Streptogramins
(Quinupristin/Dalfopristin) |
↦ Gram (+) organisms
↦ MSSA/MRSA ↦ Strep ↦ Enterococcus (VRE) |
|
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Ciprofloxacin
|
↦ Mostly Gram (+)
↦ Some Gram (–) → Pseudomonas, but not as good as other agents ↦ Atypical organisms |
↦ UTIs
↦ GNR bacteremia, bone/joint infections, hospital related infections ↦ Alternative for GNR infections in those w/ beta-lactam allergies ↦ DON'T use for respiratory infections |
|
Levofloxacin
|
↦ Mostly Gram (+)
↦ Some Gram (–) → Pseudomonas, but not as good as other agents ↦ Atypical organisms |
↦ UTIs / CAP / SSTIs / Sinusitis
↦ GNR bacteremia, bone/joint infections, and hospital related infections ↦ Alternative for GNR infections in those w/ beta-lactam allergies ↦ Alternative for mycobacterial infections |
|
Delafloxacin
|
↦ Gram (+): MRSA
↦ Some Gram (-) →Pseudomonas ↦ Atypical organisms |
↦ SSTIs
|
|
Moxifloxacin
|
↦ Mostly Gram (+)
↦ Some Gram (-) → Not as good as other agents ↦ Atypical organisms ↦ Anaerobic coverage |
↦ CAP / SSTIs
|
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Rifampin
|
↦ Mycobacterium species
↦ Gram (+) → MRSA |
↦ Never use as solo agent
|
|
Rifabutin
|
↦ Mycobacterium species
|
↦ Less DDIs → Preferred drug for patients on antiretrovirals
|
|
Rifapentine
|
↦ Mycobacterium species
|
|
|
Rifaximin
|
↦ Gram (+)
↦ Gram (-) → Enterobacteriaceae |
↦ Only active in GI tract
↦ Can’t use to treat systemic infections |
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Metronidazole
|
↦ Gram (+)
↦ Gram (–) ↦ Anaerobes ↦ Protozoa |
↦ In combo with other agents to cover anaerobes
↦ Bacterial vaginosis ↦ H. pylori treatment ↦ Crohn’s disease ↦ Giardia infections |
|
Nitrofurantoin
Fosfomycin |
↦ Gram (+) → Staph
↦ Gram (–) → Enterococcus (VRE) + GNR ↦ Fosfomycin covers ESBL |
↦ Lower UTIs
|
|
Antibiotics
|
Bacteria
|
Drug-of-Choice
|
|
Sulfonamides
(Sulfamethoxazole/trimethoprim) |
↦ Some streptococcus sp.
↦ Staphylococcus (MRSA) ↦ Enterobacteriaceae, Listeria, and Nocardia ↦ Pneumocystis jiroveci |
↦ DOC for Nocardia and Pneumocystis jiroveci
↦ UTIs / SSTIs (MRSA) ↦ Treatment of/prevention of infection in immunocompromised |
No comments yet.
Cheatography n. The art of mapping complex subjects into clear, instantly navigable reference guides.